Vaughn Bryson, former president and CEO of Eli Lilly and Co., has joined Vector Securities International Inc. as vice chairman of the board, adding a pharmaceutical industry perspective to the health care-focused investment banking firm.

In an interview with BioCentury, Bryson discussed his role at Vector and his perspective on alliances between pharmaceutical and biotechnology companies, based on his experience at Lilly.